{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:35:07Z","timestamp":1777584907211,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"IWT-TBM","award":["150178"],"award-info":[{"award-number":["150178"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00520-020-05890-3","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:07:02Z","timestamp":1606259222000},"page":"3801-3813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Breast cancer-related lymphedema and its treatment: how big is the financial impact?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-6169","authenticated-orcid":false,"given":"Tessa","family":"De Vrieze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-0434","authenticated-orcid":false,"given":"Nick","family":"Gebruers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4380-7413","authenticated-orcid":false,"given":"Ines","family":"Nevelsteen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-045X","authenticated-orcid":false,"given":"Wiebren A. A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-6264","authenticated-orcid":false,"given":"Sarah","family":"Thomis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-2836","authenticated-orcid":false,"given":"An","family":"De Groef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-6185","authenticated-orcid":false,"given":"Lore","family":"Dams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-6286","authenticated-orcid":false,"given":"Vincent","family":"Haenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-7080","authenticated-orcid":false,"given":"Nele","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"2","key":"5890_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00404-017-4421-x","volume":"296","author":"K Kast","year":"2017","unstructured":"Kast K, Schoffer O, Link T, Forberger A, Petzold A, Niedostatek A, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P (2017) Trastuzumab and survival of patients with metastatic breast cancer. Arch Gynecol Obstet 296(2):303\u2013312. https:\/\/doi.org\/10.1007\/s00404-017-4421-x","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"5890_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00432-017-2539-7","volume":"144","author":"H Eggemann","year":"2018","unstructured":"Eggemann H, Altmann U, Costa SD, Ignatov A (2018) Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer. J Cancer Res Clin Oncol 144(2):337\u2013341. https:\/\/doi.org\/10.1007\/s00432-017-2539-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5890_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/0284186x.2017.1403042","volume":"57","author":"P Christiansen","year":"2018","unstructured":"Christiansen P, Carstensen SL, Ejlertsen B, Kroman N, Offersen B, Bodilsen A, Jensen MB (2018) Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica (Stockholm, Sweden) 57(1):19\u201325. https:\/\/doi.org\/10.1080\/0284186x.2017.1403042","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"2","key":"5890_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-017-4331-4","volume":"165","author":"TI Yoon","year":"2017","unstructured":"Yoon TI, Hwang UK, Kim ET, Lee S, Sohn G, Ko BS, Lee JW, Son BH, Kim S, Ahn SH, Kim HJ (2017) Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy. Breast Cancer Res Treat 165(2):311\u2013320. https:\/\/doi.org\/10.1007\/s10549-017-4331-4","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5890_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/07347332.2013.874004","volume":"32","author":"EB Beckjord","year":"2014","unstructured":"Beckjord EB, Reynolds KA, van Londen GJ, Burns R, Singh R, Arvey SR, Nutt SA, Rechis R (2014) Population-level trends in posttreatment cancer survivors' concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. J Psychosoc Oncol 32(2):125\u2013151. https:\/\/doi.org\/10.1080\/07347332.2013.874004","journal-title":"J Psychosoc Oncol"},{"issue":"5","key":"5890_CR6","doi-asserted-by":"publisher","first-page":"e96748","DOI":"10.1371\/journal.pone.0096748","volume":"9","author":"JT Hidding","year":"2014","unstructured":"Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW (2014) Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One 9(5):e96748. https:\/\/doi.org\/10.1371\/journal.pone.0096748","journal-title":"PLoS One"},{"issue":"15","key":"5890_CR7","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.26355\/eurrev_202008_22486","volume":"24","author":"A de Sire","year":"2020","unstructured":"de Sire A, Losco L, Cisari C, Gennari A, Boldorini R, Fusco N, Cigna E, Invernizzi M (2020) Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study. Eur Rev Med Pharmacol Sci 24(15):8028\u20138035. https:\/\/doi.org\/10.26355\/eurrev_202008_22486","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5890_CR8","doi-asserted-by":"publisher","unstructured":"Yang S, Chu S, Gao Y, Ai Q, Liu Y, Li X, Chen N (2019) A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis. Cells 8(7). https:\/\/doi.org\/10.3390\/cells8070738","DOI":"10.3390\/cells8070738"},{"issue":"1","key":"5890_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12885-019-5648-7","volume":"19","author":"U Olsson M\u00f6ller","year":"2019","unstructured":"Olsson M\u00f6ller U, Beck I, Ryd\u00e9n L, Malmstr\u00f6m M (2019) A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews. BMC Cancer 19(1):472. https:\/\/doi.org\/10.1186\/s12885-019-5648-7","journal-title":"BMC Cancer"},{"issue":"3","key":"5890_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/jco.2008.17.9291","volume":"27","author":"SA Norman","year":"2009","unstructured":"Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27(3):390\u2013397. https:\/\/doi.org\/10.1200\/jco.2008.17.9291","journal-title":"J Clin Oncol"},{"issue":"8","key":"5890_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pmrj.2012.05.003","volume":"4","author":"BB Lasinski","year":"2012","unstructured":"Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM (2012) A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM & R : the journal of injury, function, and rehabilitation 4(8):580\u2013601. https:\/\/doi.org\/10.1016\/j.pmrj.2012.05.003","journal-title":"PM & R : the journal of injury, function, and rehabilitation"},{"issue":"6","key":"5890_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"issue":"7","key":"5890_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/pon.3201","volume":"22","author":"MR Fu","year":"2013","unstructured":"Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM (2013) Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-oncology 22(7):1466\u20131484. https:\/\/doi.org\/10.1002\/pon.3201","journal-title":"Psycho-oncology"},{"key":"5890_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-84628-793-0_3","volume-title":"Lymphedema","author":"CLLB Morgan","year":"2008","unstructured":"Morgan CLLB (2008) Classification and staging of lymphedema. In: Lymphedema. Springer, USA, pp 21\u201330"},{"issue":"6","key":"5890_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","volume":"26","author":"J Boyages","year":"2017","unstructured":"Boyages J, Xu Y, Kalfa S, Koelmeyer L, Parkinson B, Mackie H, Viveros H, Gollan P, Taksa L (2017) Financial cost of lymphedema borne by women with breast cancer. Psycho-oncology 26(6):849\u2013855. https:\/\/doi.org\/10.1002\/pon.4239","journal-title":"Psycho-oncology"},{"issue":"4","key":"5890_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C (2014) Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 20(4):327\u2013337. https:\/\/doi.org\/10.3350\/cmh.2014.20.4.327","journal-title":"Clin Mol Hepatol"},{"key":"5890_CR17","doi-asserted-by":"publisher","unstructured":"Hens W, Vissers D, Annemans L, Gielen J, Van Gaal L, Taeymans J, Verhaeghe N (2018) Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region: a cost-of-illness analysis. Archives of public health = Archives belges de sante publique. 76:42. https:\/\/doi.org\/10.1186\/s13690-018-0285-1","DOI":"10.1186\/s13690-018-0285-1"},{"issue":"6","key":"5890_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00006199-200311000-00004","volume":"52","author":"JM Armer","year":"2003","unstructured":"Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52(6):370\u2013379","journal-title":"Nurs Res"},{"issue":"12","key":"5890_CR19","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/jco.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007\u20132014. https:\/\/doi.org\/10.1200\/jco.2008.18.3517","journal-title":"J Clin Oncol"},{"key":"5890_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2018.12.009","volume":"44","author":"A Michelotti","year":"2019","unstructured":"Michelotti A, Invernizzi M, Lopez G, Lorenzini D, Nesa F, De Sire A, Fusco N (2019) Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management. Breast (Edinburgh, Scotland) 44:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2018.12.009","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"5890_CR21","doi-asserted-by":"publisher","unstructured":"Invernizzi M, Runza L, De Sire A, Lippi L, Blundo C, Gambini D, Boldorini R, Ferrero S, Fusco N (2020) Integrating augmented reality tools in breast cancer related lymphedema prognostication and diagnosis. J Vis Exp 156. https:\/\/doi.org\/10.3791\/60093","DOI":"10.3791\/60093"},{"issue":"1","key":"5890_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2522\/ptj.20100167","volume":"92","author":"NL Stout","year":"2012","unstructured":"Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey CL, Danoff JV, Gerber LH, Soballe PW (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92(1):152\u2013163. https:\/\/doi.org\/10.2522\/ptj.20100167","journal-title":"Phys Ther"},{"issue":"1","key":"5890_CR23","first-page":"3","volume":"53","author":"The Diagnosis and Treatment of Peripheral Lymphedema","year":"2020","unstructured":"The Diagnosis and Treatment of Peripheral Lymphedema (2020) Consensus Document of the International Society of Lymphology (2020). Lymphology 53(1):3\u201319","journal-title":"Lymphology"},{"key":"5890_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejogrb.2017.07.035","volume":"216","author":"N Gebruers","year":"2017","unstructured":"Gebruers N, Verbelen H, De Vrieze T, Vos L, Devoogdt N, Fias L, Tjalma W (2017) Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol 216:245\u2013253. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.07.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5890_CR25","unstructured":"International Lymphoedema Framework I (2006) Best practice for the management of lymphoedema: International Consensus."},{"issue":"2","key":"5890_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00520-019-05101-8","volume":"28","author":"T De Vrieze","year":"2020","unstructured":"De Vrieze T, Nevelsteen I, Thomis S, De Groef A, Tjalma WAA, Gebruers N, Devoogdt N (2020) What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Support Care Cancer 28(2):439\u2013449. https:\/\/doi.org\/10.1007\/s00520-019-05101-8","journal-title":"Support Care Cancer"},{"key":"5890_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejogrb.2017.12.023","volume":"221","author":"T De Vrieze","year":"2017","unstructured":"De Vrieze T, Vos L, Gebruers N, Tjalma WAA, Thomis S, Neven P, Nevelsteen I, De Groef A, Vandermeeren L, Belgrado JP, Devoogdt N (2017) Protocol of a randomised controlled trial regarding the effectiveness of fluoroscopy-guided manual lymph drainage for the treatment of breast cancer-related lymphoedema (EFforT-BCRL trial). Eur J Obstet Gynecol Reprod Biol 221:177\u2013188. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"5890_CR28","first-page":"401","volume":"29","author":"N Devoogdt","year":"2010","unstructured":"Devoogdt N, Lemkens H, Geraerts I, Van Nuland I, Flour M, Coremans T, Christiaens MR, Van Kampen M (2010) A new device to measure upper limb circumferences: validity and reliability. Int Angiol 29(5):401\u2013407","journal-title":"Int Angiol"},{"issue":"6","key":"5890_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00520-014-2539-y","volume":"23","author":"KH Schmitz","year":"2015","unstructured":"Schmitz KH, DiSipio T, Gordon LG, Hayes SC (2015) Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. Support Care Cancer 23(6):1807\u20131817. https:\/\/doi.org\/10.1007\/s00520-014-2539-y","journal-title":"Support Care Cancer"},{"key":"5890_CR30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","volume":"27","author":"LT Dean","year":"2018","unstructured":"Dean LT, Moss SL, Ransome Y, Frasso-Jaramillo L, Zhang Y, Visvanathan K, Nicholas LH, Schmitz KH (2018) \"It still affects our economic situation\": long-term economic burden of breast cancer and lymphedema. Support Care Cancer 27:1697\u20131708. https:\/\/doi.org\/10.1007\/s00520-018-4418-4","journal-title":"Support Care Cancer"},{"key":"5890_CR31","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (R.I.Z.I.V.) (2020) Omzendbrief VI nr 2020\/17. https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/tarief_artsen_deel01_20200101corr.pdf. Accessed 18\/02\/2020"},{"key":"5890_CR32","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (R.I.Z.I.V.) (2020) Omzendbrief VI nr 2019\/368. https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/tarief_kinesitherapeuten_20200101.pdf. Accessed 18\/02\/2020"},{"key":"5890_CR33","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (R.I.Z.I.V.) (2020) Omzendbrief VI nr 2019\/363. https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/tarief_bandagisten_20200101.pdf. Accessed 18\/02\/2020"},{"key":"5890_CR34","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (R.I.Z.I.V.) (2020) Omzendbrief VI nr 2019\/332. https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/tarief_verpleegkundigen_20200101.pdf. Accessed 18\/02\/2020"},{"key":"5890_CR35","unstructured":"Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (R.I.Z.I.V.) (2020) Omzenbrief VI nr 2019\/337. https:\/\/www.riziv.fgov.be\/SiteCollectionDocuments\/tarief_revalidatie_verstrekkingen_20200101.pdf. Accessed 18\/02\/2020"},{"issue":"6","key":"5890_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/02841860902755251","volume":"48","author":"A Karki","year":"2009","unstructured":"Karki A, Anttila H, Tasmuth T, Rautakorpi UM (2009) Lymphoedema therapy in breast cancer patients: a systematic review on effectiveness and a survey of current practices and costs in Finland. Acta Oncologica (Stockholm, Sweden) 48(6):850\u2013859. https:\/\/doi.org\/10.1080\/02841860902755251","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"11","key":"5890_CR37","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.14442","volume":"31","author":"M Gutknecht","year":"2017","unstructured":"Gutknecht M, Herberger K, Klose K, Purwins S, Dietz D, Blome C, Augustin M (2017) Cost-of-illness of patients with lymphoedema. J Eur Acad Dermatol Venereol 31(11):1930\u20131935. https:\/\/doi.org\/10.1111\/jdv.14442","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"5890_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/eujp.1999.0140","volume":"3","author":"ME Goossens","year":"1999","unstructured":"Goossens ME, Evers SM, Vlaeyen JW, Rutten-van Molken MP, van der Linden SM (1999) Principles of economic evaluation for interventions of chronic musculoskeletal pain. Eur J Pain (London, England) 3(4):343\u2013353. https:\/\/doi.org\/10.1053\/eujp.1999.0140","journal-title":"Eur J Pain (London, England)"},{"issue":"1","key":"5890_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/08870446.2014.953532","volume":"30","author":"SM Evers","year":"2015","unstructured":"Evers SM, Hiligsmann M, Adarkwah CC (2015) Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies. Psychol Health 30(1):52\u201371. https:\/\/doi.org\/10.1080\/08870446.2014.953532","journal-title":"Psychol Health"},{"issue":"7","key":"5890_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0895-4356(99)00177-8","volume":"53","author":"ME Goossens","year":"2000","unstructured":"Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM (2000) The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 53(7):688\u2013695","journal-title":"J Clin Epidemiol"},{"key":"5890_CR41","unstructured":"Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) (2020) Gecommentarieerd Geneesmiddelenrepertorium. https:\/\/www.bcfi.be\/nl\/chapters. Accessed 18\/02\/2020"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05890-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05890-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T06:15:17Z","timestamp":1622182517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05890-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5890"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05890-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"n\/a","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}